PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WST vs. ALGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


WSTALGN
YTD Return-6.90%-7.38%
1Y Return-4.46%-11.08%
3Y Return (Ann)-1.75%-24.61%
5Y Return (Ann)23.49%-3.08%
10Y Return (Ann)23.41%16.64%
Sharpe Ratio-0.12-0.20
Daily Std Dev30.08%45.97%
Max Drawdown-55.52%-92.80%
Current Drawdown-30.12%-65.23%

Fundamentals


WSTALGN
Market Cap$24.28B$19.24B
EPS$7.60$6.06
PE Ratio43.6442.18
PEG Ratio6.721.96
Revenue (TTM)$2.93B$3.92B
Gross Profit (TTM)$1.14B$2.64B
EBITDA (TTM)$809.60M$816.78M

Correlation

-0.50.00.51.00.4

The correlation between WST and ALGN is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

WST vs. ALGN - Performance Comparison

In the year-to-date period, WST achieves a -6.90% return, which is significantly higher than ALGN's -7.38% return. Over the past 10 years, WST has outperformed ALGN with an annualized return of 23.41%, while ALGN has yielded a comparatively lower 16.64% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


2,000.00%4,000.00%6,000.00%8,000.00%December2024FebruaryMarchAprilMay
7,093.98%
1,366.03%
WST
ALGN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


West Pharmaceutical Services, Inc.

Align Technology, Inc.

Risk-Adjusted Performance

WST vs. ALGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Align Technology, Inc. (ALGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WST
Sharpe ratio
The chart of Sharpe ratio for WST, currently valued at -0.12, compared to the broader market-2.00-1.000.001.002.003.004.00-0.12
Sortino ratio
The chart of Sortino ratio for WST, currently valued at 0.04, compared to the broader market-4.00-2.000.002.004.006.000.04
Omega ratio
The chart of Omega ratio for WST, currently valued at 1.01, compared to the broader market0.501.001.502.001.01
Calmar ratio
The chart of Calmar ratio for WST, currently valued at -0.11, compared to the broader market0.002.004.006.00-0.11
Martin ratio
The chart of Martin ratio for WST, currently valued at -0.33, compared to the broader market-10.000.0010.0020.0030.00-0.33
ALGN
Sharpe ratio
The chart of Sharpe ratio for ALGN, currently valued at -0.20, compared to the broader market-2.00-1.000.001.002.003.004.00-0.20
Sortino ratio
The chart of Sortino ratio for ALGN, currently valued at 0.03, compared to the broader market-4.00-2.000.002.004.006.000.03
Omega ratio
The chart of Omega ratio for ALGN, currently valued at 1.00, compared to the broader market0.501.001.502.001.01
Calmar ratio
The chart of Calmar ratio for ALGN, currently valued at -0.13, compared to the broader market0.002.004.006.00-0.13
Martin ratio
The chart of Martin ratio for ALGN, currently valued at -0.36, compared to the broader market-10.000.0010.0020.0030.00-0.36

WST vs. ALGN - Sharpe Ratio Comparison

The current WST Sharpe Ratio is -0.12, which is higher than the ALGN Sharpe Ratio of -0.20. The chart below compares the 12-month rolling Sharpe Ratio of WST and ALGN.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00December2024FebruaryMarchAprilMay
-0.12
-0.20
WST
ALGN

Dividends

WST vs. ALGN - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.24%, while ALGN has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
WST
West Pharmaceutical Services, Inc.
0.24%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%
ALGN
Align Technology, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

WST vs. ALGN - Drawdown Comparison

The maximum WST drawdown since its inception was -55.52%, smaller than the maximum ALGN drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for WST and ALGN. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%December2024FebruaryMarchAprilMay
-30.12%
-65.23%
WST
ALGN

Volatility

WST vs. ALGN - Volatility Comparison

The current volatility for West Pharmaceutical Services, Inc. (WST) is 5.92%, while Align Technology, Inc. (ALGN) has a volatility of 10.75%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than ALGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
5.92%
10.75%
WST
ALGN

Financials

WST vs. ALGN - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Align Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items